MG1 Pep-LNP
Cat. No.: TDLD-0126-LD68
MG1 Pep-LNP
MG1 Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) engineered with MG1 Peptide, designed to enable targeted drug delivery through peptide-mediated specific binding, enhancing therapeutic efficacy by combining lipid anchoring and stability properties. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear All
For Research Use Only. Not for Diagnostic or Treatment Applications.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | MG1 Peptide |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Related Products
GRGDNP Pep-LNP (TDLD-0126-LD98)
MET CAR mRNA-LNP (TDLD-0825-LD37)
DSS6 Pep-LNP (TDLD-0126-LD83)
FSHB Pep-LNP (TDLD-0825-LD95)
CGGGTHRPPMWSPVW Pep-LNP (TDLD-0126-LD67)
Empty LNP (TDLD-0825-LD9)
(Arg)9 Pep-LNP (TDLD-0126-LD131)
GEBP11 Pep-LNP (TDLD-0126-LD89)
Online Inquiry
